Article Information
History
- October 27, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Pooja Vaid1,2,
- Anirudha Puntambekar3,
- Pranali Kanse1,4,
- Shweta Kadu1,4,
- Piyush Agrawal5,
- Aditi Khatpe1,6,
- Rituja Banale1,4,
- Ruhi Reddy1,4,
- Devaki A. Kelkar1,4,
- Sridhar Hannenhalli7,
- L S Shashidhara1,2,8,9,
- Chaitanyanand Koppiker1,4 and
- Madhura Kulkarni1,4,*
- 1Centre for Translational Cancer Research: a joint initiative of Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission (PCCM) Pune
- 2Department of Biological Sciences, Ashoka University, Sonipat
- 3KRSNAA Diagnostics Ltd., Pune
- 4Prashanti Cancer Care Mission, Pune
- 5Department of Medical Research, SRM Medical College Hospital & Research Centre, SRMIST, Kattankulathur, Chennai
- 6School of Medicine, IUPUI, Indiana, USA
- 7Cancer Data Science Laboratory, Center for Cancer Research, NCI, NIH, Bethesda
- 8Department of Biology, Indian Institute of Science Education and Research, Pune
- 9National Centre for Biological Sciences, Bangalore
- ↵*Corresponding author: Madhura Kulkarni, PhD, Senior Scientist and DBT-Ramalingaswami Fellow, Centre for Translational Cancer Research., Indian Institute of Science Education and Research (IISER) Pune and Prashanti Cancer Care Mission, Pune, B-403, Third Floor, Main Building, Dr Homi Bhabha Road, Pashan, Pune 411 008 Maharashtra INDIA, Email: madhura.kulkarni{at}iiserpune.ac.in madhura.kulkarni{at}prashanticancercare.org
Posted October 27, 2024.
Molecular Profiling of a Triple-negative Breast Cancer Cohort in India for EGFR and AR expression analyzed for patient outcomes showed a distinct subset of cellular co-expression
